NDODERMAL sinus tumors or yolk sac tumors are rare cancers of the germ-cell-derived extraembryonic tissues. Like other cancers of germinal origin, they arise in midline sites such as the gonads, sacrococcygeal area, retroperitoneum, mediastinum, suprasellar region, and pineal gland. Intracranial endodermal sinus tumors represent 7% of primary intracranial germinal cancers, which themselves represent only 0.4% to 3.5% of primary intracranial neoplasms in Western countries. ~s Histologically, 50% of pineal gland endodermal sinus tumors are mixed and contain various proportions of other germ-cell elements including germinoma, teratoma, embryonal-cell carcinoma, and choriocarcinoma. 6'3~ Most pineal endodermal sinus tumors synthesize alpha-fetoprotein, and this marker, measured in serum and cerebrospinal fluid (CSF), may be useful for diagnosis and to assess responsiveness to treatment? 2,2~ Endodermal sinus tumors of the pineal gland are highly aggressive neoplasms and the survival rate is poor. t8
We describe a case of long-term complete remission of a pineal gland endodermal sinus tumor treated by a combination of surgery, cytotoxic chemotherapy, and radiotherapy. We review the other reported cases and stress the importance of a combined therapeutic approach in the management of this rare tumor.
Case Report
This 14-year-old boy with unremarkable medical history first presented in April, 1988, with intermittent frontal headaches beginning 2 months before. He suffered diplopia, nausea, vomiting, and drowsiness.
Examination. There was an absence of upward gaze and poor ocular convergence. Funduscopic examination disclosed papilledema without hemorrhage. No other neurological deficit was noted apart from mild ataxia. Computerized tomography revealed a pineal tumor and marked hydrocephalus (Fig. 1 left) . Serum alpha-fetoprotein and human chorionic gonadotropin (HCG) levels were raised at 1050 kU/liter (normal < 10 kU/liter) and 151 IU/liter (normal _< 4 IU/liter), respectively.
Operation. Right occipital craniotomy with tmnstentorial microsurgical excision of the lesion was performed in May, 1988. The excision appeared grossly complete ( Fig. 1 right) . Histological examination showed a malignant endodermal sinus tumor (yolk sac tumor) with a high mitotic rate and pathognomonic Schiller-Dural bodies (Fig. 2) . There was also an element of mature teratoma comprising keratinizing epithelium, smooth muscle, and endocrine-type cells.
Postoperative Course. After surgery, the hydrocephalus resolved but upward vision was still limited and diplopia on fight lateral gaze persisted. The serum HCG content fell to less than 2 IU/liter but, after an initial impressive drop to 49 kU/liter, the alpha-fetoprotein level rose to 88 and 113 kU/liter 18 and 25 days, respectively, after surgery (Fig. 3) . Alpha-fetoprotein but not HCG levels were also elevated in the CSF carcinoma; T = teratoma; Ch = protein levels eventually fell to normal 2 weeks later (Fig. 3) . A second course of POMB was given but the dose of eisplatin was reduced to 100 mg because of intense nausea and vomiting during the first course and a transient rise in creatinine and urea. A second course of ACE, together with a third dose of 10 mg methotrexate intrathecally, was then given. Finally, it was decided to consolidate the treatment with craniospinal irradiation 3 weeks after the completion of chemotherapy. The whole brain received 2880 cGy in 16 fractions over a 3-week period with a subsequent boost to the third ventricle area, to a final tumor dose of 5400 cGy in 30 fractions over 46 days using a three-field technique. Spinal irradiation (2550 cGy in 17 fractions over 25 days) completed this treatment.
Over the next year, improvement was noted in the patient's ocular movements; in particular, good upgaze was restored. Currently, 24 months after the diagnosis the patient is still clinically, biologically, and radiologically free of any disease. His pupils still react sluggishly to light and briskly to accommodation. Of note, his pituitary function is normal and his scholastic performance remains unchanged.
Discussion
Pineal endodermal sinus tumor is a very rare but highly aggressive nonseminomatous germ-cell neoplasm. Of the 29 patients reported in the literature (Tables I and 2 ), 24 were dead by 14 months after the diagnosis.
The results of surgery and/or radiotherapy without chemotherapy are very, disappointing (Table 1 ). Only two of 21 patients survived at 6.5 months and 3.5 years. Both underwent partial resection followed by craniospinal irradiation. The surgical procedure was limited to a biopsy and/or insertion of a shunt for the majority of patients. In the earlier literature, surgery for pineal tumors carried an unacceptably high mortality rate ~'2~ but. with modern techniques, resection can be countenanced. ~ The commoner germinomas of the pineal region are radiosensitive and patients are often cured by shunt placement and a therapeutic trial of radiation, ~' but it is clear that such an approach cannot be relied upon to cure the rare patient with an endodermal sinus tumor. As shown in Table 1 , no such tumor has been cured by radiotherapy alone.
The emergence of extremely effective chemotherapy for gonadal and extragonadal germ-cell tumors has changed management concepts of intracranial germcell tumors. Protocols using synergistic cytotoxic agents, including vinblastine, vincristine, acfinomycin D, bleomycin, Adriamycin, cyclophosphamide, and cisplatin, have achieved complete remission rates of 60% to 90% against localized and metastatic gonadal and extrago- We found only eight cases of pineal endodermai sinus tumor treated by chemotherapy (Table 2) . Five patients who died received chemotherapy only when the tumor was known to have recurred or metastasized. Two of three patients who received adjuvant chemotherapy were alive 13 years and 12 months after diagnosis. In the third adjuvant patient, there was an initial complete response after radiotherapy and chemotherapy, but the patient died 9 months later with local recurrence and seeding to the spine and peritoneum. Metastatic spread through the CSF and ventriculopefitoneal shunts is a well-documented risk in pineal endodermal sinus tumors. 69~2427:~3233 Our patient, alive 2 years after diagnosis, was treated with adjuvant chemotherapy following a macroscopically complete resection of the tumor. The serum alpha-fetoprotein levels (Fig. 3 ) fell initially and then rose, strongly suggesting that there was a microscopic residuum of tumor. The subsequent decrease to normal levels after the first round of POMB-ACE chemotherapy was an invaluable measure, and gave us the confidence to administer only one further course of POMB-ACE rather than an arbitrary (larger) number of cycles.
The decision to consolidate with craniospinal irradiation was not based on hard evidence, but influenced by anecdotal reports of patients with pineal tumor relapsing after an initial response to chemotherapy when radiotherapy was omitted. Radiotherapy with careful fractionation tailored to the doses used seemed to be an acceptable risk and in the event was well tolerated. There appeared to be no logic in omitting the spinal field in view of the high rate of CSF seeding described with pineal endodermal sinus tumors.
Conclusions
We report the third case of long-term survival among patients with pineal endodermal sinus tumors managed with chemotherapy as adjuvant treatment. We stress a multidisciplinary approach to pineal endodermal sinus tumors based on combined surgery, chemotherapy, and radiotherapy. Surgery allows a definite diagnosis and removes most of the tumor mass. Combination chemotherapy using a platinum-based regimen must be given as adjuvant treatment without delay. Radiotherapy (whole neuraxis irradiation) can be used to complete the treatment. The response to therapy should be monitored by serial determinations of tumor markers.
